Part of the impetus behind the creation of the APACMed in 2015, was the need to help MedTechs navigate the increasingly complex and fragmented regulatory landscape. APACMed provides access to relevant regulatory intelligence for its members, and advocates convergence in regulatory requirements where possible across Asia Pacific countries
Much of the regulatory advocacy efforts across the region coalesce around three interdisciplinary Centres of Excellence, covering: China, South East Asia, the Indian Sub-Continent. Separate Working Groups are dedicated to regulatory intelligence (RI) and invitro diagnostics (IVD). Through its Centres of Excellence and Working Groups, APACMed has successfully engaged members and fostered its networks at the local level across the region.